Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Naber

Showing results (61-70 of 195) with videos related to

Pageof 20
Sort By:
Der Nervenarzt|May 1, 1993
[HIV-antibody test and seroprevalence in inpatient psychiatric patients]C Perro, D Naber, B Löhmer, et al.
Psychopharmacology|January 1, 1989
Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patientsD Naber, M Leppig, R Grohmann, et al.
Brain Research|March 2, 1981
Circadian and seasonal rhythms in alpha- and beta-adrenergic receptors in the rat brainM S Kafka, A Wirz-Justice, D Naber
Neuroscience Letters|January 1, 1981
Circadian rhythm in rat brain opiate receptorD Naber, A Wirz-Justice, M S Kafka
Current Pharmaceutical Biotechnology|January 31, 2012
Subjective well-being of patients with schizophrenia as a target of drug treatmentE Karamatskos, C Mulert, M Lambert, et al.
Der Nervenarzt|December 5, 2000
[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]M Lambert, S Moritz, C Haasen, et al.
Psychopharmacology|January 1, 1989
Clozapine in the treatment of 121 out-patientsM Leppig, B Bosch, D Naber, et al.
Pharmacopsychiatry|December 17, 2003
Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevanceM Lambert, B Graf Schimmelmann, A Karow, et al.
Pharmacopsychiatry|September 1, 2006
Gender-specific effects in the treatment of acute schizophrenia with risperidoneT J Raedler, A Schreiner, D Naber, et al.
Acta Psychiatrica Scandinavica|May 1, 1994
Human immunodeficiency virus antibody test and seroprevalence in psychiatric patientsD Naber, F G Pajonk, C Perro, et al.
Pageof 20

Showing results (61-70 of 195) with videos related to

Sort By:
Pageof 20
Der Nervenarzt|May 1, 1993
[HIV-antibody test and seroprevalence in inpatient psychiatric patients]C Perro, D Naber, B Löhmer, et al.
Psychopharmacology|January 1, 1989
Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patientsD Naber, M Leppig, R Grohmann, et al.
Brain Research|March 2, 1981
Circadian and seasonal rhythms in alpha- and beta-adrenergic receptors in the rat brainM S Kafka, A Wirz-Justice, D Naber
Neuroscience Letters|January 1, 1981
Circadian rhythm in rat brain opiate receptorD Naber, A Wirz-Justice, M S Kafka
Current Pharmaceutical Biotechnology|January 31, 2012
Subjective well-being of patients with schizophrenia as a target of drug treatmentE Karamatskos, C Mulert, M Lambert, et al.
Der Nervenarzt|December 5, 2000
[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]M Lambert, S Moritz, C Haasen, et al.
Psychopharmacology|January 1, 1989
Clozapine in the treatment of 121 out-patientsM Leppig, B Bosch, D Naber, et al.
Pharmacopsychiatry|December 17, 2003
Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevanceM Lambert, B Graf Schimmelmann, A Karow, et al.
Pharmacopsychiatry|September 1, 2006
Gender-specific effects in the treatment of acute schizophrenia with risperidoneT J Raedler, A Schreiner, D Naber, et al.
Acta Psychiatrica Scandinavica|May 1, 1994
Human immunodeficiency virus antibody test and seroprevalence in psychiatric patientsD Naber, F G Pajonk, C Perro, et al.
Pageof 20